Jundishapur 2024
Top Research Directions
The 3 research directions with Jundishapur 2024 papers, ranked by paper count, next to 2023. Share is the fraction of the edition’s papers in the direction.
| # | Direction | 2024 | 2023 | Share 2024 | Share 2023 | 2023 rank |
|---|---|---|---|---|---|---|
| 1 | Enzyme Linked Immunosorbent Assays for Biomarker Quantification | 1 | 0 | 100.0% | 0.0% | — |
| 2 | Multiplexed Molecular Assays for Simultaneous Pathogen Detection | 1 | 1 | 100.0% | 100.0% | 4 |
| 3 | The Limits of Single Center Clinical Evidence | 1 | 0 | 100.0% | 0.0% | — |
Download all directions as CSV
About this data
Papers. Jundishapur 2024 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.
Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2023 use shares, since the edition went from 1 to 1 papers.
Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions. Cite as: Lacuna, “Jundishapur 2024”, https://lacuna.tiptreesystems.com/venue/jundishapur/2024.
Papers
| Title |
|---|
| Epidemiological Study of Respiratory Virus Infections in Pediatric Patients with Systemic Inflammatory Response Syndrome |